Strategic Partnering Opportunity to pursue distribution partnerships with larger wellness and diagnostics players similar to MedMira, given WebbDX's experience with exclusive distribution deals in the COVID-19 serology space.

Rapid Diagnostic Focus Position WebbDX as a nimble supplier of rapid diagnostic solutions for emerging and hard-to-diagnose conditions, appealing to clinics, hospitals, and mobile testing sites seeking quick, accurate results.

AI Enabled Highlight the integration of artificial intelligence with biotechnology and immunochemistry to differentiate offerings and open doors for software-enabled test interpretation, data analytics services, and remote diagnostics partnerships.

Low Buyer Risk Current revenue under one million with a small team suggests low-scale pilots and test deployments could be offered to target customers, enabling easy, low-risk engagements that scale with proven success.

Market Entry Leverage recent COVID-19 test roll-out experience to pitch rapid-response testing solutions to public health, urgent care networks, and home health providers seeking fast deployment capabilities.